Pan London Early Rectal Cancer Meeting

Ensuring patient choice and access to the PRESERVE Trial

1st November 2018, Royal Society of Medicine,  London

“I made some choices; the outcomes are good.  I remain positive.”  K.W.

Multidisciplinary teams attended a day of lectures, expert panel discussions and break out sessions to establish a consistent pathway for early rectal cancer, increasing identification of patients suitable for local excision, and developing the management pathway for early rectal cancer as outlined in the Colorectal Cancer Guidelines (previously published Cancer Alliances in London) and commissioned NHS England service specification.


Mr Ken Webster, our Patient Representative on the PRESERVE trial, agreed to take part in a panel with Dr Diana Tait and Prof Gina Brown to discuss his experiences of being diagnosed with rectal cancer, the choices he was given at his consultation and how his life has changed through the treatment he has received.  We were also able to receive comments from other patient representatives prior to the meeting that we were able to present to the audience.


“I am very pleased and relieved that the TEMs procedure was successful, thanks to the skill of the consultant and operating team.  I’m happy that the TEMs procedure could be used rather than the more invasive procedure.”  R.M.

Presentation slides

How to set up and maintain the SPECC early rectal cancer MDT   Mr Francesco Di Fabio

Identification and pathway of lesions for organ-preserving local excision approach    Dr Kevin Monahan

Endoscopic submucosal dissection of rectal lesions   Dr Paul O’Toole

TEM TAMIS patient selection  Mr Chris Cunningham

TEM full-thickness techniques and TAMIS  Mr Tony Miles

Improving precision of staging SPECC and early rectal lesions, and road-mapping for local excision    Prof Gina Brown

PRESERVE Project launch    Miss Annabel Shaw

Adjuvant therapy – selective post-excision therapy in moderate and high risk cancers to enable organ preservation   Dr Diana Tait

Assessment and onward guidance following local excision. Defining high, moderate and low risk cancers   Prof Marco Novelli

Early Rectal Cancer Translational research opportunities    Dr Katharina von Loga

Endoscopic submucosal dissection of rectal lesions    Mr Amyn Haji

How to set up and access support for PRESERVE in your hospital  Mr Graham Branagan


Delegates attended from:   Amsterdam UMCBasingstoke North Hampshire HospitalBrighton and Sussex University Hospital NHS TrustChelsea & Westminster NHS Foundation TrustChurchill Hospital, OxfordCroydon University HospitalEast and North Herts NHS TrustEast Suffolk and North Essex Foundation TrustEpsom and St Helier University HospitalsHampshire Hospitals NHS TrustImperial College Healthcare NHS TrustKing’s College Hospital NHS Foundation TrustLondon North West University Healthcare NHS TrustOxford University HospitalsRM Partners (London Cancer Alliance)Royal Liverpool and Broadgreen University HospitalsRoyal Marsden NHS Foundation TrustSalisbury NHS Foundation TrustSt George’s University Hospitals NHS Foundation TrustSt Mark’s Hospital; University College London Hospitals NHS Foundation Trust; University Hospitals of North Midlands